Kyphon to acquire InnoSpine
This article was originally published in The Gray Sheet
Executive Summary
Purchased firm's catheter-based Functional Anesthetic Discography, 510(k)-cleared in April, could be indicated for the nearly 200,000 patients with severe axial back pain, Kyphon says. Under the deal, expected to close this month, Kyphon will pay $2.5 mil. in cash upfront to InnoSpine shareholders, with $27.5 mil. contingent on clinical milestones. InnoSpine's device, which delivers anesthetic, radiopaque contrast or saline to spinal discs to determine which disc is degenerating and causing pain, uses existing CPT codes for reimbursement...